InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Browse the complete record of transactions filed by Hexter Joshua, 首席执行官. Director active across 1 company, notably Oramed Pharmaceuticals INC.. Cumulatively, 12 reports have been recorded. Activity tracked since 11 February 2025. The latest transaction was filed on 17 March 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Hexter Joshua
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
95,889 股0Common StockSEC:0001213900-26-031012:0
19,000 股0Common StockSEC:0001213900-26-009477:0
97,328 股0Common StockSEC:0001213900-26-001278:0
45,000 股0Common StockSEC:0001213900-25-012240:0
194,500 股Common StockSEC:0001213900-25-001165:0
30,000 股Common StockSEC:0001213900-24-095929:0
180,500 股Common StockSEC:0001209191-24-001148:0
27,000 股Common StockSEC:0001209191-23-033142:0
108,000 股Common StockSEC:0001209191-23-024940:0
42,000 股Common StockSEC:0001209191-22-043767:0
21,000 股Common StockSEC:0001213900-22-000807:0
33,333 股Common StockSEC:0001213900-21-046410:0
12 条申报中的 12 条
About Hexter Joshua
Hexter Joshua is Chief Executive Officer and Commercial Director. He is associated with Oramed Pharmaceuticals INC. (XNAS) as COO & CBO. The declarant has 12 filings in total, and across the 12 sampled filings the most frequent transaction nature is Award, with publications from 2021-09-02 to 2026-03-18.
